2019-842 Health - Walgreens drug dispense

Browse Search

Zeldywco'L to becoming a Blocked Drug shall be subject to the Aged Drug or Slow Moving Drug replenishment process , as applicable . In the event a Covered Entity prescriber writes a prescription for a Blocked Drug, Covered Entity acknowledges and agrees such prescription shall be considered a Non - Eligible 340B Drug and Walgreens may collect the Usual and Customary Charge from the patient . 4 . 3 . 4 . Covered Entity will reimburse Walgreens the Inventory Replenishment Rate for Aged Drugs and Slow Moving Drugs . 4 . 4 . Tracking System . Walgreens maintains proprietary electronic tracking software that is capable of tracking 340B Drugs received from the Supplier, preventing the diversion of 340B Drugs to individuals who are not Eligible Patients , and verifying that such diversion has not occurred ( " 34013 Complete ° " ) . 340B Complete ° shall be able to provide comparisons of Eligible Patient prescriptions and dispensing records and a comparison of 340B Drug purchasing and dispensing records . Walgreens will reasonably cooperate with Covered Entity to address any potential irregularities detected in 340B Complete ° and will make adjustments to 340B Complete ° that are reasonably necessary to prevent diversion of 340B Drugs to individuals who are not Eligible Patients . Notwithstanding the foregoing , however, Covered Entity acknowledges and agrees it is the sole responsibility of the Covered Entity to review the Report and information available in 340E Complete ° to confirm that no diversion has occurred and that the Report and 340B Complete ° are tools provided by Walgreens to assist Covered Entity in that review . Covered Entity agrees to report any suspected instance of diversion to Walgreens within forty -five ( 45 ) days from the end of the month in which the prescription was dispensed and upon the mutual agreement of the parties , Walgreens shall make adjustments to the claim ( e . g . , reclassify the product as a Non - Eligible 340B Drug ) . 4 . 5 . Inventory Reconciliation . On a monthly basis , Walgreens will reconcile 340B Drug inventory using the information available in the Report and 340B Complete ° , and make any necessary financial or accumulator adjustments as described below ( " Reconciliation " ) . Reconciliation shall be conducted at the NDG11 level and only apply with respect to pharmaceuticals that have reached full package size , or are an Aged Drug or Slow Moving Drug, and for which Walgreens has or should have received replenishment from the Supplier . 4 . 5 . 1 . Non - Eligible Patients and Excess Replenishment. In the event Walgreens determines that 340B Drugs have been dispensed to non - Eligible Patients or that the quantity of 340B Drugs provided to Walgreens exceeds the quantity of 340B Drugs dispensed to Eligible Patients hereunder, Walgreens will adjust the virtual inventory so that such excess is applied against existing or future 340B Drug prescriptions dispensed hereunder . If such inventory credits are not depleted by subsequent 340B dispenses from Pharmacy Locations , Walgreens will reimburse Covered Entity for such remaining drugs in accordance with the wholesale acquisition cost . Covered Entity shall be responsible for assessing if the adjustment is the result of any noncompliance and if so determine whether it is required to self- disclose the noncompliance per HRSA guidelines . Walgreens shall not contact a drug manufacturer regarding a 340B Drug purchased by Covered Entity without the express prior approval of Covered Entity . The parties acknowledge and agree that Covered Entity shall remain ultimately responsible for the compliance of its 340B Drug Program and any corresponding self- reporting as necessary . With respect to adjustments made for dispenses of 340B Drugs to non - Eligible Patients , the following additional financial adjustments will apply : 7of24 MAT- 63397 OrangeCountyHD - WAG 340B 10312019 ( be ) V1 . 0 © 2019 Walgreen Co . All rights reserved .